20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
77.39.Z - Rental and leasing of other machinery, equipment, and tangible assets, not elsewhere classified
2023 | 2024 | ||
---|---|---|---|
M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | -0,3 | -283,2 |
Gross profit (loss) | 0,2 | -0,3 | -269,6 |
EBITDA | 0,2 | -0,3 | -258,9 |
Short time liabilities | 0,1 | 0 | -62,8 |
Other operating costs | 0 | 0 | 244,4 |
Equity capital | 1,2 | 0,7 | -40,9 |
Operating profit (EBIT) | 0,2 | -0,3 | -274 |
Assets | 1,3 | 0,7 | -43 |
Net profit (loss) | 0,2 | -0,3 | -287,5 |
Cash | 0,7 | 0 | -100 |
Liabilities and provisions for liabilities | 0,1 | 0 | -62,8 |
Net income from sale | 2,2 | 0,2 | -92,2 |
Working assets | 1,3 | 0,7 | -43 |
Other income costs | 0 | 0 | 9560,3 |
Depreciation | 0 | 0 | 47,4 |
% | % | p.p. | |
Profitability of capital | 13,1 | -41,6 | -54,7 |
Equity capital to total assets | 90,6 | 93,8 | 3,2 |
Gross profit margin | 7,8 | -168,2 | -176 |
EBITDA Margin | 8,4 | -169,7 | -178,1 |
Days | Days | Days | |
Short term commitment turnover cycle | 20 | 97 | 77 |
Current financial liquidity indicator | 10.412569999694824 | 15.944761276245117 | 5,5 |
Net dept to EBITDA | -3.703981876373291 | 0 | 3,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane